Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

Disorders of the Skeletal Muscle

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...

Alterations in Muscle Tone lll

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...

Satellite Stem Cells and Muscular Dystrophy

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cross-national biologic treatment guidelines for FMF: a comparative analysis.

Rheumatology (Oxford, England)·2026

Same author

Predictors of inactive disease and remission in children and young adults with juvenile idiopathic arthritis treated with etanercept.

Rheumatology (Oxford, England)·2026

Same author

Immunotherapy of esophageal, GEJ and gastric tumors

Magyar onkologia·2025

Same author

Comparative analysis of global practices in the management of colchicine-resistant familial Mediterranean fever: a CliPS network analysis.

RMD open·2025

Same author

Examination of Behavioral and Neuropsychological Characteristics of Hungarian Patients with Juvenile Idiopathic Arthritis: A Cross-Sectional Analysis.

Children (Basel, Switzerland)·2025

Same author

Monitoring of Juvenile Idiopathic Arthritis-Associated Uveitis in Long-Term Disease Remission: Consensus-Based Recommendations From the Multinational Interdisciplinary Working Group for Uveitis in Childhood.

Arthritis care & research·2025

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Paraneoplastic myopathy.

Katalin Dankó¹, Andrea Ponyi, Andrew P Molnar

¹Division of Clinical Immunology, 3rd Department of Internal Medicine, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary. katalin.danko@gmail.com

Current Opinion in Rheumatology

|September 5, 2009

Summary

This summary is machine-generated.

Patients with idiopathic inflammatory myopathies (IIM) have an increased risk of malignancy. New autoantibody discoveries may improve diagnosis and understanding of cancer-associated myositis, guiding future cancer screening.

More Related Videos

A Preclinical Model of Sepsis-Induced Myopathy with Disuse in Mice

A Preclinical Model of Sepsis-Induced Myopathy with Disuse in Mice

Published on: June 14, 2024

Related Experiment Videos

Last Updated: Jun 20, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

A Preclinical Model of Sepsis-Induced Myopathy with Disuse in Mice

A Preclinical Model of Sepsis-Induced Myopathy with Disuse in Mice

Published on: June 14, 2024

Area of Science:

Rheumatology
Oncology
Immunology

Background:

Idiopathic inflammatory myopathies (IIM) are associated with an elevated risk of malignancy.
Cancer-associated myositis often exhibits paraneoplastic features.

Purpose of the Study:

To review new data on the connection between myositis and malignancy.
To highlight the value of this connection in managing IIM patients.

Main Methods:

Review of recent clinical findings and immunoserological testing.
Analysis of antigen expressions in regenerating muscle and cancers.

Main Results:

Shared antigen expressions suggest a potential antitumor immune response in myositis.
The anti-155/140 autoantibody aids in diagnosing malignancy risk in adult IIM patients.
Understanding paraneoplastic myositis is enhanced by new discoveries.

Conclusions:

Cancer-associated myositis is distinct from primary myositis, with prognosis dictated by the underlying cancer.
Patient-specific cancer detection is crucial for managing IIM.
Future evidence-based recommendations for cancer screening in IIM patients are anticipated.